Real-time enrollment status for this hypochondroplasia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT07126262 |
| Recruiting Status | Recruiting |
| Condition | Hypochondroplasia |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 9 sites in the US |
| Sponsor | BioMarin Pharmaceutical |
| Last Updated on CT.gov | August 17, 2025 (Aug 17, 2025) |
As of March 2, 2026: Clinical trial NCT07126262 is currently recruiting participants. This clinical trial study for hypochondroplasia is actively seeking new participants at 9 locations across the United States. The study is sponsored by BioMarin Pharmaceutical. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07126262 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07126262 was last updated Aug 17, 2025 (August 17, 2025). HelloStudys verifies this status automatically.